Internal Medicine, Endocrinology, Diabetes, & Metabolism · Topeka, KS
NPI
1568683365
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
3520 SW 6th Ave
Topeka, KS, 66606
Phone (785) 354-9591
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
1,763 services
Medicare patients, 2024
491
Average age 73
Drug cost, 2024
$1.8M
5,934 prescriptions
Company payments, 2025
$45.74
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco J Correa was code 36415 (venipuncture blood collection), 748 times for 399 patients. In total Francisco J Correa billed 1,763 services in 23 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 748 | 399 | $8.63 | $6,456 |
| 99214 Office E&M - Established | Office | 531 | 342 | $78.55 | $42K |
| 99215 Office E&M - Established | Office | 252 | 148 | $118.51 | $30K |
| 95251 Test - Miscellaneous | Office | 96 | 50 | $25.09 | $2,408 |
| 99204 Office E&M - New | Office | 49 | 49 | $99.50 | $4,876 |
| 99205 Office E&M - New | Office | 19 | 19 | $93.71 | $1,781 |
| 83036 Blood Count | Office | 17 | 15 | $9.52 | $162 |
| 99213 Office E&M - Established | Office | 11 | 11 | $54.34 | $598 |
By year: 2022 $77K for 1,482 services; 2023 $88K for 1,632 services; 2024 $92K for 1,763 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 748 | 399 | $8.63 | $6,456 |
| 83036 Blood Count | 17 | 15 | $9.52 | $162 |
Medicare prescription drug claims, 2024
In 2024, the drug Francisco J Correa prescribed most often to Medicare patients was Levothyroxine Sodium, with 590 prescriptions and refills. In total Francisco J Correa wrote 5,934 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 590 | 1,292 | 151 | $5,078 |
| Metformin Hcl Er Metformin Hcl | 500 | 1,134 | 127 | $4,732 |
| Ozempic Semaglutide | 349 | 467 | 62 | $432K |
| Glipizide Er Glipizide | 324 | 778 | 96 | $3,138 |
| Atorvastatin Calcium Generic | 288 | 734 | 87 | $1,752 |
| Jardiance Empagliflozin | 276 | 546 | 64 | $310K |
| Euthyrox Levothyroxine Sodium | 205 | 428 | 43 | $1,267 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 196 | 439 | 70 | $24K |
| Tresiba Flextouch U-100 Insulin Degludec | 161 | 305 | 48 | $90K |
| Metformin Hcl Generic | 158 | 390 | 43 | $916 |
| Januvia Sitagliptin Phosphate | 143 | 237 | 30 | $128K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 138 | 376 | 60 | $12K |
| Glipizide Generic | 135 | 285 | 43 | $556 |
| Unithroid Levothyroxine Sodium | 135 | 297 | 38 | $4,101 |
| Pioglitazone Hcl Generic | 121 | 323 | 40 | $1,578 |
Brand drugs: 2,950 claims; generic drugs: 2,719 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco J Correa $45.74 ($45.74 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $45.74.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 2 | $45.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.